Hob Biotech Group Suzhou Co., Ltd. logo

Hob Biotech Group Suzhou Co., Ltd. (688656)

Market Closed
11 Aug, 06:57
SSE SSE
¥
92. 15
+1.45
+1.5987%
¥
5.52B Market Cap
- P/E Ratio
1.6% Div Yield
540,020 Volume
- Eps
¥ 90.7
Previous Close
Add Transaction
Day Range
88.52 95.58
Year Range
76.62 217
Want to track 688656 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688656 closed today higher at ¥92.15, an increase of 1.5987% from yesterday's close, completing a monthly decrease of -5.7482% or -¥5.62. Over the past 12 months, 688656 stock lost -40.4023%.
688656 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 9 months on May 29, 2027 for a total of ¥0.2.
The last earnings report, released on Oct 28, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688656 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Hob Biotech Group Suzhou Co., Ltd. (688656) FAQ

What is the stock price today?

The current price is ¥92.15.

On which exchange is it traded?

Hob Biotech Group Suzhou Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688656.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.6%.

What is its market cap?

As of today, the market cap is 5.52B.

Has Hob Biotech Group Suzhou Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Hob Biotech Group Suzhou Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. John Li CEO
SSE Exchange
CNE100004C37 ISIN
CN Country
550 Employees
29 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

HOB Biotech Group Corp., Ltd. is a prominent in vitro diagnostic company with a global presence, headquartered in Suzhou, China. Since its inception in 2009, the company has been dedicated to enhancing the care of patients suffering from allergies and autoimmune diseases. Through its innovative diagnostic tools, HOB Biotech Group has established itself as a crucial partner to laboratories and hospitals around the world, aiming to improve patient outcomes with advanced and reliable testing solutions.

Products and Services

  • Line Immune Assays - These are advanced diagnostic tests designed for the accurate detection of specific antibodies or antigens related to various allergies and autoimmune diseases. These tests are known for their precision and reliability, providing critical information that aids in the diagnosis and management of these conditions.
  • Enzyme-Linked Immunosorbent Assays (ELISA) - ELISA kits offered by HOB Biotech Group are vital tools in the diagnosis of allergic and autoimmune diseases. This technology employs a plate-based assay technique to detect and quantify soluble substances such as peptides, proteins, antibodies, and hormones. The sensitivity and specificity of ELISA make it an indispensable method in clinical laboratories.
  • Chemiluminescent Paramagnetic Microparticle Immunoassays - These sophisticated immunoassays use chemiluminescence for the detection and quantification of various biochemical markers in different samples. This technology combines the high sensitivity of chemiluminescence with the precision of paramagnetic microparticle capture, offering unparalleled accuracy in diagnostic testing.

Contact Information

Address: Building C6 and C10, Suzhou, China, 215123
Phone: 86 512 6956 1996